Free Trial

The Cigna Group (NYSE:CI) Stock Price Expected to Rise, Truist Financial Analyst Says

The Cigna Group logo with Medical background
Remove Ads

The Cigna Group (NYSE:CI - Get Free Report) had its price target lifted by Truist Financial from $375.00 to $385.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm currently has a "buy" rating on the health services provider's stock. Truist Financial's price objective indicates a potential upside of 17.22% from the stock's current price.

Other analysts have also issued research reports about the stock. Barclays lowered their price objective on shares of The Cigna Group from $420.00 to $339.00 and set an "overweight" rating for the company in a research note on Friday, January 31st. Royal Bank of Canada set a $355.00 price objective on shares of The Cigna Group in a research report on Friday, January 31st. Stephens decreased their target price on The Cigna Group from $410.00 to $380.00 and set an "overweight" rating for the company in a research report on Friday, January 31st. Raymond James reissued a "strong-buy" rating and issued a $360.00 price target (down previously from $415.00) on shares of The Cigna Group in a research report on Friday, January 31st. Finally, Guggenheim assumed coverage on The Cigna Group in a report on Wednesday, April 9th. They set a "buy" rating and a $384.00 price objective for the company. Two research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and three have issued a strong buy rating to the stock. Based on data from MarketBeat, The Cigna Group presently has a consensus rating of "Buy" and an average target price of $373.56.

Read Our Latest Research Report on The Cigna Group

Remove Ads

The Cigna Group Trading Down 0.2 %

Shares of CI traded down $0.76 during mid-day trading on Friday, reaching $328.44. 1,082,558 shares of the company were exchanged, compared to its average volume of 1,840,119. The stock has a market capitalization of $89.89 billion, a PE ratio of 26.83, a PEG ratio of 0.98 and a beta of 0.51. The business has a 50 day simple moving average of $312.75 and a two-hundred day simple moving average of $310.94. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66. The Cigna Group has a 52 week low of $262.03 and a 52 week high of $370.83.

The Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 earnings per share for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same quarter last year, the firm earned $6.79 EPS. On average, analysts predict that The Cigna Group will post 29.77 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Elder Granger sold 2,376 shares of the company's stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $310.35, for a total value of $737,391.60. Following the transaction, the director now directly owns 5,471 shares in the company, valued at approximately $1,697,924.85. This represents a 30.28 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Noelle K. Eder sold 9,944 shares of The Cigna Group stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $320.00, for a total transaction of $3,182,080.00. Following the sale, the insider now owns 13,406 shares of the company's stock, valued at approximately $4,289,920. The trade was a 42.59 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 43,751 shares of company stock worth $13,603,991 in the last three months. Corporate insiders own 0.70% of the company's stock.

Institutional Investors Weigh In On The Cigna Group

Hedge funds have recently added to or reduced their stakes in the company. Garden State Investment Advisory Services LLC bought a new position in The Cigna Group during the third quarter valued at approximately $444,000. Sunbelt Securities Inc. lifted its stake in The Cigna Group by 24.9% in the third quarter. Sunbelt Securities Inc. now owns 216 shares of the health services provider's stock worth $75,000 after purchasing an additional 43 shares during the last quarter. TD Private Client Wealth LLC grew its stake in shares of The Cigna Group by 4.0% during the third quarter. TD Private Client Wealth LLC now owns 6,181 shares of the health services provider's stock valued at $2,141,000 after buying an additional 235 shares during the last quarter. Advisory Resource Group increased its holdings in shares of The Cigna Group by 2.0% in the third quarter. Advisory Resource Group now owns 13,163 shares of the health services provider's stock worth $4,560,000 after buying an additional 263 shares during the period. Finally, Virtu Financial LLC lifted its stake in shares of The Cigna Group by 39.6% in the 3rd quarter. Virtu Financial LLC now owns 17,173 shares of the health services provider's stock valued at $5,949,000 after acquiring an additional 4,870 shares during the last quarter. Institutional investors own 86.99% of the company's stock.

About The Cigna Group

(Get Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Read More

Analyst Recommendations for The Cigna Group (NYSE:CI)

Should You Invest $1,000 in The Cigna Group Right Now?

Before you consider The Cigna Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Cigna Group wasn't on the list.

While The Cigna Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now
5 International Stocks to Escape U.S. Market Volatility

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads